Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Novartis, a global medicines company, has announced a planned USD 23 billion investment over 5 years in US-based ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

Hundreds of New Jersey workers will be out of a job this year as several major companies slash their workforces, according to ...

EAST HANOVER, N.J., March 20, 2025 /PRNewswire/ -- Novartis today announced that oral Fabhalta® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of ...

Baseball has only one division in which all five teams seem to be actively trying to win, and it’s the high-profile, high-powered American League East. The AL East has sent three teams to the ...

EAST HANOVER, N.J., March 20, 2025 -- Novartis today announced that oral Fabhalta ® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 ...

Basel, March 20, 2025 – Novartis today announced that oral Fabhalta ® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G) ...

Novartis has been among the largest so far in 2025, with plans to cut 427 U.S. jobs reporting into its East Hanover site ... trans school board president in NJ denies online ‘leak’ ‘I ...

Novartis Pharmaceuticals is removing hundreds of New Jersey employees from its company. The global drugmaker will lay off 427 employees from its U.S. headquarters in East Hanover, according to a ...